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Magnetic resonance imagingThe cerebral cortex is highly convoluted, and principal folding patterns are determined early in life. Degree of cor-
tical folding in adult life may index aberrations in brain development. Results from previous studies of cortical
folding in schizophrenia are inconsistent. Here we investigated cortical folding patterns in the hitherto largest
sample of patients with schizophrenia drawn from two independent cohorts. Magnetic resonance imaging
scans were acquired from 207 patients and 206 healthy subjects recruited to two separate research projects in
Sweden and Norway. Local gyriﬁcation index (lGI) was estimated continuously across the cortex using automat-
ed methods. Group differences in lGI were analyzed using general linear models. Patients had lower lGI in three
large clusters of the cortex with peak differences found in the left precentral gyrus, right middle temporal gyrus,
and right precuneus. Similar, although not completely overlapping results were found when the two cohorts
were analyzed separately. There were no signiﬁcant interaction effects between age and diagnosis and gender
and diagnosis. The ﬁnding of reduced degree of folding in large regions of the cerebral cortex across two indepen-
dent samples indicates that reduced gyriﬁcation is an inherent feature of the brain pathology in schizophrenia.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Theﬁrst clinicalmanifestation of schizophrenia usually occurs in late
adolescence or early adulthood, but genetic and epidemiological ﬁnd-
ings suggest that the disease process involves alterations in early brain
development to the developing brain (Weinberger, 1987; Rapoport
et al., 2012). Neurodevelopment occurs in a programmed and gradual
fashion with cortical neurons migrating to their destination before
birth (Bystron et al., 2008). Major cortical folding patterns are mainly
determined before birth and undergo only minor changes in childhood
and adolescence. Importantly, the degree of folding relative to brain size
remains relatively stable from early childhood (Armstrong et al., 1995;
Zilles et al., 2013), and is thus a suitable subject for investigation of
early brain development. A range of methods for measuring corticald Addiction, Institute of Clinical
Oslo, Norway. Tel.: +47 22 02
z).
ghts reserved.folding has been developed (Mangin et al., 2010; White et al., 2010).
The most widely used method is the gyriﬁcation index (GI), i.e. the
ratio between the folded cortical surface and an outer cerebral surface
tightly warping the brain without entering the sulci (Zilles et al.,
1988). One of the authors of the present paper (MS) has developed an
automated method for measuring vertex-wise gyriﬁcation in three-
dimensional (3D) space across the entire cortex based onmagnetic res-
onance imaging (MRI) data (Schaer et al., 2008).
Findings from MRI studies of gyriﬁcation in schizophrenia have
been mixed, as reviewed by White and Hilgetag (2011). Both reduced
(e.g. Sallet et al., 2003) and increased (e.g. Falkai et al., 2007) GI have
been found using manual or automated methods on coronal sections
of MR images, and one study did not ﬁnd signiﬁcant group differences
(Highley et al., 2003). Higher GI in prefrontal cortex has been found
among high-risk patients who later developed schizophrenia compared
to those who did not (Harris et al., 2004, 2007). Studies using the auto-
mated lGI method have shown reduced folding in the right prefrontal
cortex among patients with adolescent onset (Janssen et al., 2009)
and adult onset schizophrenia (Palaniyappan et al., 2011), and reduced
334 R. Nesvåg et al. / Schizophrenia Research 152 (2014) 333–338folding in the left insula and medial parieto-occipital cortex in adult
onset schizophrenia (Palaniyappan and Liddle, 2012).
Given the discrepant ﬁndings in the literature, it is still unclear if,
where, and towhat extent the cortex is abnormally folded in schizophre-
nia. In the present study, the automated lGI method was applied to a
large group of patients with schizophrenia and healthy subjects drawn
from a Swedish sample with predominantly long-term treated patients,
and a Norwegian sample with a high proportion of patients with recent
onset schizophrenia. Our aimwas to test if patients and controls differed
in degree of cortical folding across two large independent samples.2. Materials and methods
2.1. Participants
A total of 207 patientswith schizophrenia (N = 165), schizoaffective
disorder (N = 34) or schizophreniform disorder (N = 8) and 206
healthy control subjectswere recruited as part of the Human Brain Infor-
matics (HUBIN) project in Stockholm, Sweden between 1999 and 2003,
and the Thematically Organized Psychosis (TOP) project in Oslo, Norway
between 2003 and 2008. Details regarding subject recruitment and clin-
ical procedures have been described and evaluated previously (Ekholm
et al., 2005; Engh et al., 2010). Patients were assessed for lifetime psychi-
atric diagnoses according to DSM-IIIR or DSM-IV based on hospital case
notes and structured clinical interviews (Spitzer et al., 1988; First et al.,
2002) performed by trained psychiatrists or psychologists. Symptoms
were rated according to the Scale for the Assessment of Negative Symp-
toms, SANS (Andreasen, 1983) and the Scale for the Assessment of
Positive Symptoms, SAPS (Andreasen, 1984) in Sweden, and the Positive
and Negative Syndrome Scale, PANSS (Kay et al., 1987) in Norway. Cur-
rent doses of antipsychotic medication were converted to deﬁned daily
doses according to guidelines provided by the World Health Organiza-
tion (http://www.whocc.no/atcddd/). See Table 1 for details regarding
demographic and clinical data.
Healthy control subjects were recruited based on population regis-
ters (Sweden and Norway) or among hospital staff (Sweden only).Table 1
Demographic and clinical data.
Swedish sample (n = 201) Nor
Patients (n = 95) Controls (n = 106) Test Pat
Gender (% men) 73.7 67.9 ns 58.9
Age (y) 42.2 (7.1) 41.5 (9.0) ns 31.8
Age at onset (y)e 24.6 (5.9) na 27.1
Duration (y)f 17.4 (8.7) na 4.7
Education (y) 12.5 (2.8) 14.1 (2.9) t = 3.8; p b 0.001 13.1
PANSS positive na na 14.4
PANSS negative na na 14.5
PANSS general na na 30.9
PANSS total score na na 59.9
SANS total score 28.0 (19.0) na na
SAPS total score 18.6 (26.5) na na
AP medication (DDD)h 0.9 (0.7) na 1.6
All data shown as mean (SD) unless otherwise speciﬁed. Abbreviations: ns, not signiﬁcant; y, y
Assessment of Negative symptoms; SAPS, Scale for the Assessment of Positive Symptoms; AP, a
Education: 11; PANSS general and PANSS total score: 1, SANS total score: 42, SAPS total score:
a Tests for differences between samples.
b Test for difference in the patient-control ratio between samples.
c Test for difference in gender distribution between samples irrespective of diagnostic group
d Test for difference in mean age between samples irrespective of diagnostic group.
e Age at onset of illness was deﬁned as onset of psychotic symptoms according to any sourc
f Duration of illness was deﬁned as the time difference between age at onset and age at inve
g Test for difference in mean education between samples irrespective of diagnostic group.
h In the Swedish sample, 88 patients received antipsychotic medication (40 typical, 41 atypi
tipsychotic medication at the time of investigation. In the Norwegian sample, 100 patients rece
and atypical), while eleven patients did not receive antipsychotic medication at the time of invThe controls had no psychotic disorders as determined by a structured
clinical interview (Spitzer et al., 1986) in Sweden, and by the Primary
Care Evaluation of Mental Disorders (Spitzer et al., 1994) in Norway,
and no severe mental disorders among ﬁrst-degree relatives. Exclusion
criteria were a history of head trauma with loss of consciousness for
more than 5 min, or somatic disorders affecting brain function. After
complete description of the study, all subjects gave written informed
consent to participate. The HUBIN study was approved by the Research
Ethics Committee at Karolinska Institutet, and the TOP study was ap-
proved by the Regional Committee for Medical Research Ethics and
the Norwegian Data Inspectorate. Both studies were conducted accord-
ing to the Helsinki declaration.
2.2. MR methods
2.2.1. Scan acquisition
Imaging data was collected using 1.5 T MR systems (GE Signa
in Sweden and Siemens Magnetom Sonata in Norway). In Sweden, T1-
weighted volumes were acquired using a three dimensional spoiled
gradient recalled (SPGR) pulse sequence with the following parame-
ters: 124 coronal slices, 35° ﬂip angle, repetition time 24 ms, echo
time 6.0 ms, voxel size 0.86 × 0.86 × 1.50 mm. In Norway, two T1-
weighted volumes were acquired using a magnetization prepared
rapid gradient echo (MPRAGE) pulse sequence (Siemens tﬂ3d1_ns)
with the following parameters: 160 sagittal slices, 7° ﬂip angle, repeti-
tion time 2730 ms, echo time 3.93 ms, voxel size 1.33 × 0.94 × 1 mm
and averaged during post-processing to increase the signal to noise
ratio. All MRI scans were found to lack gross pathology when evaluated
by a neuroradiologist.
2.2.2. MR image processing
MRI data were processed using FreeSurfer, v 5.3.0 (http://surfer.
nmr.mgh.harvard.edu/). 3D representations of the pial and the gray/
white matter border were estimated using automated procedures
(Dale et al., 1999; Fischl et al., 1999, 2001). Topological defects were
manually edited, and the individual brain surfaces were morphed to awegian sample (N = 212) Testa
ients (n = 112) Controls (n = 100) Test nsb
42.0 Χ2 = 11.6; p = 0.003 Χ2 = 16.8; p b 0.001c
(8.6) 37.6 (10.2) t = 4.5; p b 0.001 t = 8.2; p b 0.001d
(8.3) na t = 2.5; p = 0.013
(5.0) na t = 12.5; p b 0.001
(2.7) 14.2 (2.3) t = 3.2; p = 0.002 nsg
(5.5) na
(6.3) na
(7.7) na
(15.8) na
na
na
(1.2) na t = 5.2; p b 0.001
ears; na, not applicable; PANSS, Positive and Negative Syndrome Scale; SANS, Scale for the
ntipsychotic; DDD, deﬁned daily doses. Missing data: Age at onset: 2, Duration of illness: 2,
43, AP medication: 1.
.
e.
stigation.
cal, and seven a combination of typical and atypical), while seven patients received no an-
ived antipsychotic medication (six typical, 83 atypical, and eleven a combination of typical
estigation.
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(Fischl and Dale, 2000).
2.2.3. Local gyriﬁcation index (lGI)
Based on the pial surface reconstruction, an algorithm formeasuring
3D lGI at each vertex across each hemisphere was performed. Details of
the lGI computation can be found in the validation paper (Schaer et al.,
2008) and at https://surfer.nmr.mgh.harvard.edu/fswiki/LGI.
The lGI method is adapted from the classical 2D GI (Zilles et al.,
1988). First, an outer envelope that tightly wraps the pial cortical sur-
face is created. Second, local measurement of circular GI is computed
for each vertex of the outer surface as the ratio of corresponding regions
of interest (ROI) on the outer envelope and pial surface. Delineation of
the ROI on both the outer surface (ROIO) and pial surface (ROIP) uses a
matching algorithm based on geodesic constraints, so that the ROIP de-
lineates the entire patch of the cortical surface within the circular pe-
rimeter of the ROIO. Thus, at the end of the computational process,
individual lGI corticalmaps quantify the amount of cortex buriedwithin
the sulcal folds in the surrounding circular region.
For statistical analysis, individual lGI maps were registered to the
fsaverage template included in FreeSurfer and smoothed using an itera-
tive nearest neighbor averaging procedure, with full width at a half
maximum of 5 mm.
2.3. Statistical analysis
Differences in demographic and clinical variables between patients
and controls within and across each sample were analyzed using Chi-
square test and Student's T-test in the software IBM SPSS Statistics,
v.20 (SPSS Inc., Chicago, IL, USA).
Differences in lGI between patients and controls in the two samples
separately and combined were analyzed by ﬁtting a general linear
model at each vertex on the surface. Age and sex were included as co-
variates in the separate samples, and age, sex and sample were con-
trolled for in the combined sample analysis. Non-parametric cluster-
wise correction for multiple comparisons was performed using the
Monte Carlo simulation tool embedded in FreeSurfer (Hagler et al.,
2006) with an initial cluster-forming threshold of p b .05. Clusters
with an empirical p b .05 were regarded signiﬁcant, fully corrected for
multiple comparisons across space. Group comparisons were also
rerun after excluding patients with schizoaffective disorder.
Mean lGIwithin clusters showing signiﬁcant groupdifferences in the
combined samplewere obtained for estimation and comparison of com-
monly reported effect sizes and post-hoc analyses to test the relative
contribution of age, gender, and diagnosis, as well as age × diagnosis
and gender × diagnosis interactions on variation in lGI. For the latter
purpose a generalized linear model was ﬁtted in SPSS, with age, sex,
and diagnosis in addition to age × diagnosis and sex × diagnosis as
predictors. Sample was entered as an additional covariate. Agewas cen-
tered on the mean within the entire sample. To test for any association
between lGI and age at onset and duration of illness, partial correlation
analyses controlling for gender and sample were performed. Since
age was highly correlated with age at onset and duration of illness
(r = .44 and r = .72, respectively), patients were split into arbitrarily
chosen age groups (19–24, 25–29, 30–34, 35–39, 40–44, and 45–
49 years) in the partial correlation analyses between lGI and age of
onset and duration of illness. To test for associations between lGI
and clinical measures (dose of antipsychotic medication, dose of
medication × duration of illness as proxy for cumulative dose, and se-
verity of positive and negative symptoms), partial correlation analyses
were performed. Due to differences in distribution of medication types
and choice of symptom scales across samples, type of medication and
sample were entered as covariates in the analyses. The level for statisti-
cal signiﬁcance was adjusted for multiple comparisons using the
Bonferroni correction (alpha = 0.05/number of tests).3. Results
3.1. Demographic and clinical variables
Patients and controls in the Swedish sample were older than pa-
tients and controls in the Norwegian sample (Table 1). Duration of ill-
ness was longer and dose of antipsychotic medication was lower
among Swedish compared to Norwegian patients. Norwegian patients
were younger than Norwegian controls.
3.2. Whole cortex analysis
In the combined sample, patients had signiﬁcantly lower lGI in three
clusters; left lateral pericentral cortex, right temporo-occiptal cortex
and right medial parietal cortex (Fig. 1, upper panel). Similar clusters
were found when the Swedish and Norwegian samples were analyzed
separately. In the Swedish sample, all three clusters were smaller, but
were similar in locationwhen compared to those in the combined sam-
ple (Fig. 1,middle panel). In theNorwegian sample, the cluster in the left
pericentral region was conﬁned to the precentral gyrus, the cluster in
right temporal cortex included parts of the lateral frontal cortex, while
the right medial parietal cluster was similar in location and magnitude
to that in the combined analysis (Fig. 1, lower panel). There were no re-
gions with signiﬁcantly higher lGI among patients. Information on loca-
tion and size of signiﬁcant clusters are shown in Table 2. Removing the
schizoaffective disorder patients did not change the results.
3.3. Cluster-wise analyses
Higher age was related to lower mean lGI within the left pericentral
and right temporo-occipital clusters (Table 3). Women had lower lGI in
all three clusters. Therewere no signiﬁcant age × diagnosis or sex × di-
agnosis interaction effects. For patients aged 25–29 years, later onset of
illness was related to lower lGI and longer duration of illness was relat-
ed to higher lGI in the left pericentral cluster, while for patients aged
30–34 years, later onset was related to lower lGI and longer duration
was related to higher lGI in the left pericentral and right medial parietal
clusters (Table 4). Age of onset or duration of illness was not related to
lGI in the right temporo-occipital cluster. There were no signiﬁcant cor-
relations between lGI and type, dose or duration of antipsychotic med-
ication, or severity of positive or negative symptomswhen adjusting for
multiple comparisons.
4. Discussion
4.1. Group differences
The main ﬁnding of this study was reduced cortical folding in three
large brain regions in patients with schizophrenia. The ﬁndings were
similar, although not entirely overlapping, in the two samples. Previous
studies fromour group have demonstrated reduced cortical thickness in
prefrontal and temporal regions (Nesvåg et al., 2008; Rimol et al., 2010)
and reduced cortical area in circumscribed regions of the brain (Rimol
et al., 2012) among the patients. Interestingly, the latter study found
reduced cortical area in the left pericentral and right lateral temporal
regions, similar to regions with reduced lGI in the present study. Post-
mortem studies have demonstrated that cortical area in the brain of
an adult monkey is dependent on the number of proliferative units in
the developing brain, while cortical thickness is dependent on the num-
ber and size of neurons within each proliferative unit (Rakic, 1988).
Although cortical area and thickness are both highly heritable, the ge-
netic correlation between them is weak (Panizzon et al., 2009). Given
that gyriﬁcationmeasures the amount of surface enclosed in a restricted
space, it is not surprising to ﬁnd results in similar direction and location
using either gyriﬁcation or measuring regional areas. In healthy adults,
cortical thickness is determined by complex maturational changes
Fig. 1.Colormaps showing clusterswith signiﬁcantly lower local gyriﬁcation index (lGI) in patients with schizophrenia comparedwith controls from two independent cohorts, one Swed-
ish sample from theHuman Brain Informatics (HUBIN) project, and one Norwegian from the Thematically Organized Psychosis (TOP) research project. Corrected cluster-wise signiﬁcance
levels in the combined, Swedish and Norwegian samples are shown in yellow (p b 0.0005), orange (p b 0.005), and red (p b 0.05).
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face area is less affected by maturational changes (Raznahan et al.,
2011). This may explain the weak correlation between cortical thick-
ness and gyriﬁcation or cortical area (Hogstrom et al., in press). In
neurodevelopmental disorders, such as schizophrenia, thematurational
mechanisms for cortical thickness and gyriﬁcation or areamay be differ-
entially affected, thus potentially even decreasing the alreadyweak cor-
relation. Previous work from our group on a smaller, but overlapping
sample from the Swedish cohort, demonstrated that a history of obstet-
ric complications affected cortical folding (Haukvik et al., 2012), but not
cortical thickness (Haukvik et al., 2009). In a large diagnostically hetero-
geneous sample from the Norwegian cohort, Haukvik et al. (2013)
found that birth weight was correlated with cortical area across diag-
nostic groups, but notwith cortical thickness. This suggests that reduced
cortical folding and reduced cortical area represent similar pathophysi-
ologicalmechanisms in schizophrenia,whichpresumably involves early
alterations in neurodevelopment, while reduced cortical thickness is re-
lated to other pathophysiological processes.
Our ﬁnding of reduced gyriﬁcation in left pericentral and right
temporo-occipital cortex is partly convergent with two previous
studies using the automated lGI method in patients with adolescent
onset (Palaniyappan et al., 2013a) and adult onset schizophreniaTable 2
Description of clusters with signiﬁcant group differences in local gyriﬁcation index.
Sample Cluster Location of
Combined Left pericentral Left precen
Right temporo-occipital Right midd
Right medial parietal Right precu
Swedish Left pericentral Left supram
Right temporo-occipital Right midd
Right medial parietal Right precu
Norwegian Left pericentral Left precen
Right fronto-temporal Right cauda
Right medial parietal Right precu
Abbreviations: lGI, local gyriﬁcation index; CWP, cluster-wise probability (of group difference(Palaniyappan and Liddle, 2012). Hypogyria in bilateral insular, left
frontal and right temporal regions have been linked to lack of response
to antipsychotic medication in ﬁrst-episode psychosis patients
(Palaniyappan et al., 2013b). Furthermore, Cachia et al. (2008) found
that medication-resistant hallucinations were related to reduced fold-
ing of the left pericentral cortex. In the present study, no signiﬁcant cor-
relationwas found between severity of positive and negative symptoms
and degree of cortical folding. However, our cross-sectional study did
not allow for investigation of relationships with longitudinal outcome
measures, such as response to treatment.
4.2. Relationship with age
Whereas increasing age was related to decreasing lGI in the left
pericentral and right medial parietal clusters, age was not related to
lGI in the right temporo-occipital cluster. Reduced cortical gyriﬁcation
with increasing age may be due to reduced sulcal depth (Kochunov
et al., 2005). In a study of gyriﬁcation in healthy adults aged between
20 and 85 years, lGI was negatively correlated with age in all major
lobes of the brain, including regions in which groups differed in the
present study (Hogstrom et al., in press). In a recent longitudinal
study assessing trajectories of lGI change with age in a large sample ofpeak vertex Area (mm2) CWP
tral gyrus 12,480 0.0001
le temporal gyrus 5940 0.0001
neus 5165 0.0001
arginal gyrus 6156 0.0001
le temporal gyrus 2579 0.0048
neus 3612 0.0002
tral 1796 0.047
l middle frontal gyrus 6851 0.0001
neus 3506 0.0002
in lGI).
Table 3
Inﬂuence of age, gender and diagnosis on variation in mean local gyriﬁcation index per clustera.
Left pericentral cluster Right temporo-occipital cluster Right medial parietal cluster
B Testa p B Testb p B Testb p
Intercept 3.35 50,500 b0.000001 3.55 22,334 b0.000001 3.23 29,628 b0.000001
Age (10 years)c −0.064 48.0 b0.000001 −0.065 19.2 0.00001 0.010 0.73 0.39
Gender (women)d −0.052 8.22 0.004 −0.155 28.1 b0.000001 −0.050 4.66 0.031
Diagnosis −0.062 14.2 0.0002 −0.080 9.32 0.002 −0.073 12.6 0.0004
Sample (Swedish)e 0.036 6.27 0.012 0.425 351.2 b0.000001 −0.24 173.6 b0.000001
Age ∗ diagnosis −0.013 1.00 0.32 −0.015 0.464 0.50 −0.016 0.89 0.35
Gender ∗ diagnosis 0.026 1.05 0.31 0.080 3.76 0.053 −0.003 0.007 0.93
a Generalized linear models with mean lGI within each cluster as dependent variable, age, gender and diagnosis as covariates, and age–diagnosis and gender–diagnosis as interaction
terms. Sample was entered as covariate in all models, but the parameter estimates for sample is not shown in the table.
b Wald Chi-square.
c Age was centered on the mean within the entire sample and divided by 10 to obtain test values for a 10 years interval.
d Test values are presented for women when men are set to zero.
e Test values are presented for the Swedish sample when the Norwegian sample is set to zero.
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found a linearly decreasing lGI with age in most cortical regions, with
the exception of the medial prefrontal and cuneus/precuneus regions
where lGI did not correlate with age. As such, the localization of our
two clusters with decreased lGI with age and the cluster without signif-
icant age-related decrease is largely in agreement with the topological
distribution of the trajectories reported by Mutlu et al. The absence of
signiﬁcant age × diagnosis interaction effect in the present study sug-
gests that group differences in lGI are independent of age.4.3. Relationship with age at onset and duration of illness
Age at onset was negatively correlated with lGI in two of three clus-
ters, but conﬁned to younger patients. This was an unexpected ﬁnding,
given that patients with early onset of disease presumably have more
perturbations in brain morphology. However, the ﬁnding indicates
that timing of disease onset may not be strongly related to cortical fold-
ing. Age, age at onset and duration of illness are highly correlated,which
makes it difﬁcult to disentangle the speciﬁc contribution of each of the
variables. Putative associations between cortical gyriﬁcation and
onset/duration of illness may better be studied using a prospective de-
sign. In the two-year longitudinal study of adolescent-onset schizophre-
nia patients by Palaniyappan et al. (2013a), patients had higher lGI in
the left lateral frontal cortex and lower lGI in the right lateral temporal
cortex at baseline. Longitudinally, however, patients showed more re-
duction than controls in lateral frontal cortex lGI, while patients and
controls had similar reductions in right lateral temporal lGI. Although
based on a small sample, the results indicate that early onset of schizo-
phrenia may be related to higher lGI in the frontal cortex, and that the
association between duration of illness and lGI differs across the cortex.
Our ﬁnding of a relationship between higher lGI and earlier onset
among the younger patients is partly supported by studies of subjects
at high risk for developing psychosis, where hypergyria in rightTable 4
Relationshipsa between mean local gyriﬁcation index per cluster and age at onset and duration
Left pericentral cluster Right tempor
Onset Duration Onset
Age, years r p r p r
19–24 (N = 30) −0.16 0.41 0.035 0.86 −0.12
25–29 (N = 28) −0.58 0.002 0.55 0.003 −0.39
30–34 (N = 36) −0.52 0.002 0.46 0.006 −0.48
35–39 (N = 27) −0.13 0.54 0.081 0.70 −0.28
40–44 (N = 36) 0.12 0.52 −0.17 0.35 0.096
45–49 (N = 42) 0.026 0.87 −0.067 0.681 −0.062
a Partial correlation coefﬁcients between mean lGI within each cluster and age at onset of illn
ﬁcients are marked by bold text. Abbreviations: N, number of patients within each age intervaprefrontal cortex was found in subjects who later developed schizo-
phrenia compared to subjects who did not (Harris et al., 2004, 2007),
while hypogyria in left hemisphere were found in high-risk subjects
compared to controls (Jou et al., 2005).4.4. Strengths and limitations
We applied a validated, automated 3Dmethodwith high spatial res-
olution in the hitherto largest sample of patients with schizophrenia
drawn from two independent cohorts. Limitations include the use of
different MR scanners and acquisition parameters in the two samples,
differences in age and duration of illness within and across samples,
and inadequate data to investigate effects of antipsychotic medication
and symptoms for variation in lGI.4.5. Conclusions
Results from the present study suggest that reduced gyriﬁcation in
left pericentral, right lateral temporal, and right medial parietal cortex
is an inherent factor of the brain pathology in schizophrenia, which
might serve as a quantitative phenotype in genetic association studies.Role of funding source
This work was supported by grants from the East Norway Health Authority (grant
number #2005-135), the Norwegian Research Council (grant numbers 160181/V50,
204966/F20 and 190311), the Swiss National Science Foundation (grant numbers 3200-
063135.00/1, 3232-063134.00/1, PP0033-102864 and 32473B-121996), theNational Cen-
ter of Competence in Research (NCCR) “SYNAPSY — The Synaptic Bases of Mental Dis-
eases” ﬁnanced by the Swiss National Science Foundation (grant number
51AU40_125759), the Swedish Research Council (grant numbers 2006-2992, 2006-986
and 2008-2167), the regional agreement on medical training and clinical research be-
tween Stockholm County Council and the Karolinska Institutet and the Knut and Alice
Wallenberg Foundation. The funding sources played no part in design, analysis, interpre-
tation or presentation of results.of illness.
o-occipital cluster Right medial parietal cluster
Duration Onset Duration
p r p r p r p
0.55 0.022 0.91 0.031 0.88 −0.07 0.72
0.052 0.36 0.072 0.099 0.63 −0.17 0.41
0.004 0.42 0.014 0.18 0.31 −0.20 0.26
0.28 0.19 0.35 −0.091 0.67 0.099 0.64
0.59 −0.11 0.53 0.18 0.32 −0.16 0.37
0.70 −0.015 0.92 0.15 0.35 −0.16 0.33
ess and duration of illness, controlling for gender and sample. Nominally signiﬁcant coef-
l.
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